https://www.selleckchem.com/pr....oducts/gsk3368715.ht
iral therapy engagement for the prevention of HIV transmission through viral suppression. Understanding to whom benefits accrue may be important in assessing the equity and impact of HIV investments. Some HIV+ patients, virally suppressed on ART, show occasional "blips" of detectable HIV-1 plasma RNA. We used a new highly sensitive assay of cell-associated HIV-1 RNA to measure transcriptional activity in PBMCs and production of infectious virus from the viral reservoir, in patients with and without "blips". RNA and DNA extracted from